arrow
L

Lanwei Guo

Zhengzhou University
H指数:30
被引数:3,110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol

单臂、开放标签、多中心Ib/II期研究,旨在评估 fruquintinib 联合 sintilimab 和 CAPEOX 作为晚期胃或胃食管结合部腺癌一线治疗的 safety 和 efficacy(FUNCTION 研究):一项研究方案

2025-09-260
PRE
Facilitators and barriers to evidence adoption for central venous catheters post-insertion maintenance in oncology nurses: a multi-center mixed methods study

肿瘤科护士中心静脉导管置入后维护证据采纳的促进因素和障碍: 一项多中心混合方法研究

2024-08-210
OAAI
Research progress on sexual functioning and associated factors in childhood cancer survivors: a scoping review

儿童癌症幸存者性功能及其相关因素的研究进展: 范围综述

2024-07-010
OAAI
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
2022-09-284
OAAI
Special issue The advance of solid tumor research in China: Participants with a family history of cancer have a higher participation rate in low-dose computed tomography for lung cancer screening

中国实体瘤研究进展: 有癌症家族史的参与者在低剂量计算机断层扫描肺癌筛查中的参与率更高

2022-04-202
OA